Project BEST: Buprenorphine Entry Into Substance Abuse Treatment
| Status: | Completed |
|---|---|
| Conditions: | Depression, HIV / AIDS, Gastrointestinal, Hepatitis, Hepatitis |
| Therapuetic Areas: | Gastroenterology, Immunology / Infectious Diseases, Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 4/21/2016 |
| Start Date: | May 2005 |
| End Date: | August 2008 |
Project BEST is a clinical project funded by the Substance Abuse and Mental Health Services
Administration (SAMHSA) to increase treatment to opiate dependent patients with mental
illness in New Haven, CT and to prospectively follow everyone enrolled in buprenorphine care
for as long as the individual takes buprenorphine to track the success of buprenorphine for
the maintenance of opiate dependence.
Administration (SAMHSA) to increase treatment to opiate dependent patients with mental
illness in New Haven, CT and to prospectively follow everyone enrolled in buprenorphine care
for as long as the individual takes buprenorphine to track the success of buprenorphine for
the maintenance of opiate dependence.
The investigators propose to create a prospective cohort that will track outcomes for an
opiate dependent population on buprenorphine maintenance. Individuals who have already
decided to undergo buprenorphine treatment in Project BEST will be invited to participate in
the following data collection process. The investigators propose the following series of
data collection to assess clients during their time in the cohort:
GPRA, supplemental instrument, ASI, SCID, COWS, Urine toxicology.
Patients who are enrolled will enter a standardized, manual based weekly counseling regimen.
Urine toxicology will be performed a minimum of twice monthly, but will not occur at the
same times monthly to decrease the probability of sampling error.
This is a prospective cohort to follow a group of individuals on buprenorphine treatment.
The goal of this prospective cohort is to generate thoughtful observations. Specific items
of interest which will be compared with age, race matched historical controls on methadone
will be:
1. Changes in addiction severity over treatment time
2. Changes in sexual risk behaviors and injection practices
3. Improvements in urine toxicology
4. Co-occurring mental illness
opiate dependent population on buprenorphine maintenance. Individuals who have already
decided to undergo buprenorphine treatment in Project BEST will be invited to participate in
the following data collection process. The investigators propose the following series of
data collection to assess clients during their time in the cohort:
GPRA, supplemental instrument, ASI, SCID, COWS, Urine toxicology.
Patients who are enrolled will enter a standardized, manual based weekly counseling regimen.
Urine toxicology will be performed a minimum of twice monthly, but will not occur at the
same times monthly to decrease the probability of sampling error.
This is a prospective cohort to follow a group of individuals on buprenorphine treatment.
The goal of this prospective cohort is to generate thoughtful observations. Specific items
of interest which will be compared with age, race matched historical controls on methadone
will be:
1. Changes in addiction severity over treatment time
2. Changes in sexual risk behaviors and injection practices
3. Improvements in urine toxicology
4. Co-occurring mental illness
Inclusion Criteria:
- Opiate dependent by DSM IV criteria - to be determined by clinician - on
buprenorphine through the Project BEST Program.
Exclusion Criteria:
- Inability to adhere to study instruments.
We found this trial at
1
site
Yale University Yale's roots can be traced back to the 1640s, when colonial clergymen led...
Click here to add this to my saved trials
